Ameriprise Financial Inc Amphastar Pharmaceuticals, Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 144,598 shares of AMPH stock, worth $6.52 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

144,598

Previous 123,913 16.69%

Holding current value

$6.52 Million

Previous $4.96 Million 41.59%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$36.99 - $50.09 $765,138 - $1.04 Million	20,685 Added 16.69%	144,598 $7.02 Million
Q2 2024 Aug 14, 2024	SELL	$38.65 - $43.48 $414,173 - $465,931	-10,716 Reduced 7.96%	123,913 $4.96 Million
Q1 2024 May 15, 2024	SELL	$42.85 - $63.45 $198,224 - $293,519	-4,626 Reduced 3.32%	134,629 $5.91 Million
Q4 2023 Feb 14, 2024	SELL	$44.49 - $62.93 $463,318 - $655,353	-10,414 Reduced 6.96%	139,255 $8.61 Million
Q3 2023 Nov 14, 2023	SELL	$45.51 - $65.0 $622,804 - $889,525	-13,685 Reduced 8.38%	149,669 $6.88 Million
Q2 2023 Aug 14, 2023	SELL	$35.77 - $58.38 $210,506 - $343,566	-5,885 Reduced 3.48%	163,354 $9.39 Million
Q1 2023 May 15, 2023	SELL	$27.99 - $37.92 $156,212 - $211,631	-5,581 Reduced 3.19%	169,239 $6.35 Million
Q4 2022 Feb 14, 2023	SELL	$27.93 - $31.27 $504,806 - $565,173	-18,074 Reduced 9.37%	174,820 $4.9 Million
Q3 2022 Nov 14, 2022	SELL	$27.56 - $37.75 $88,357 - $121,026	-3,206 Reduced 1.63%	192,894 $5.42 Million
Q2 2022 Aug 15, 2022	BUY	$29.79 - $42.29 $247,733 - $351,683	8,316 Added 4.43%	196,100 $6.82 Million
Q1 2022 May 16, 2022	SELL	$22.96 - $36.45 $39,606 - $62,876	-1,725 Reduced 0.91%	187,784 $6.74 Million
Q4 2021 Feb 14, 2022	BUY	$18.14 - $23.29 $19,464 - $24,990	1,073 Added 0.57%	189,509 $4.41 Million
Q3 2021 Nov 15, 2021	SELL	$17.83 - $21.49 $91,539 - $110,329	-5,134 Reduced 2.65%	188,436 $3.58 Million
Q2 2021 Aug 16, 2021	SELL	$17.11 - $20.92 $8,828 - $10,794	-516 Reduced 0.27%	193,570 $3.9 Million
Q1 2021 May 17, 2021	BUY	$17.21 - $20.65 $106,736 - $128,071	6,202 Added 3.3%	194,086 $3.56 Million
Q4 2020 Feb 12, 2021	SELL	$17.76 - $21.24 $1.4 Million - $1.68 Million	-78,876 Reduced 29.57%	187,884 $3.78 Million
Q3 2020 Nov 16, 2020	SELL	$17.99 - $22.22 $452,538 - $558,944	-25,155 Reduced 8.62%	266,760 $5 Million
Q2 2020 Aug 14, 2020	SELL	$14.25 - $22.46 $46,341 - $73,039	-3,252 Reduced 1.1%	291,915 $6.56 Million
Q1 2020 May 15, 2020	SELL	$12.66 - $20.08 $210,852 - $334,432	-16,655 Reduced 5.34%	295,167 $4.38 Million
Q4 2019 Feb 14, 2020	SELL	$17.07 - $20.64 $121,640 - $147,080	-7,126 Reduced 2.23%	311,822 $6.02 Million
Q3 2019 Nov 14, 2019	BUY	$19.12 - $22.62 $2.44 Million - $2.88 Million	127,423 Added 66.53%	318,948 $6.33 Million
Q2 2019 Aug 14, 2019	BUY	$18.92 - $22.96 $10,973 - $13,316	580 Added 0.3%	191,525 $4.04 Million
Q1 2019 May 15, 2019	SELL	$19.46 - $25.28 $1.09 Million - $1.42 Million	-56,132 Reduced 22.72%	190,945 $3.9 Million
Q4 2018 Feb 14, 2019	BUY	$17.72 - $22.51 $929,360 - $1.18 Million	52,447 Added 26.95%	247,077 $4.92 Million
Q3 2018 Nov 14, 2018	SELL	$15.39 - $19.38 $30,164 - $37,984	-1,960 Reduced 1.0%	194,630 $3.74 Million
Q2 2018 Aug 14, 2018	BUY	$14.63 - $19.6 $165,319 - $221,480	11,300 Added 6.1%	196,590 $3 Million
Q1 2018 May 15, 2018	BUY	$17.23 - $20.35 $76,156 - $89,947	4,420 Added 2.44%	185,290 $3.48 Million
Q4 2017 Feb 12, 2018	SELL	$17.76 - $19.75 $60,206 - $66,952	-3,390 Reduced 1.84%	180,870 $3.48 Million
Q3 2017 Nov 07, 2017	BUY	$14.73 - $17.99 $2.71 Million - $3.31 Million	184,260	184,260 $3.29 Million

Others Institutions Holding AMPH

# of Institutions

283

Shares Held

35.1M

Call Options Held

57K

Put Options Held

22.3K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $2.21B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Amphastar Pharmaceuticals, Inc. Transaction History